Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

This study is looking for women between 18 and 75 years old who have been diagnosed with breast cancer that hasn't spread to other parts of their body (non-metastatic). Your doctors must have decided that hormone therapy, such as anti-oestrogen or anti-aromatase drugs, is the right treatment for you after your initial cancer treatment.

To take part, you should be able to read and understand French, as some materials might be in this language, and have access to the internet, as some information will be collected online. You must also be generally well enough to participate in daily activities and willing to give your written permission to join the study.

There are some reasons why you wouldn't be able to join. For example, if your cancer has spread, if you've already started hormone therapy before the study, or if you've been treated for another cancer within the last two years. If you're pregnant or breastfeeding, or have certain cognitive or mental health conditions, you also wouldn't be able to participate. Also, if you’re in the group receiving the special programme, you need to be able to attend initial hospital workshops; similarly, if you're in the usual care group, you shouldn't already have plans for similar intensive phone or education support.

If you decide to take part in this study, you would either receive the special education and nursing support programme or continue with your usual excellent care. Regardless of which group you're in, the study will involve collecting information about how you're feeling and any side effects you experience over the first year of your hormone therapy treatment. This will mainly be done through questionnaires on an online platform.

If you are in the special programme group, you would attend an initial assessment day at the hospital and some group workshops. You would also receive regular phone calls from a nurse for ongoing support. If you're in the usual care group, you'd continue with your standard medical appointments and follow-up as advised by your healthcare team.

The overall duration of your participation in the study would be for the first year that you are receiving hormone therapy. There are no specific medications provided by the study, as it focuses on supporting you through the hormone therapy your doctors have already prescribed.